|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Cell Biology, Physiology and Immunology, Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain
2 Department of Pharmacology, Universitat Autonoma de Barcelona, Bellaterra, Barcelona, Spain
* To whom correspondence should be addressed. E-mail: maite.martin{at}uab.es.
Background: We previously reported that indomethacin induces a chronic intestinal inflammation in the rat where the cyclical characteristic phases of Crohn's disease are manifested with a few days' interval and lasting for several months: active phase (high inflammation, hypomotility, bacterial traslocation) and reactive phase (low inflammation, hypermotility, no bacterial traslocation). Aims: In this study we investigated the possible role of both constitutive and inducible isoforms of nitric oxide synthase (NOS) and cyclooxygenase (COX) in the cyclicity of active and reactive phases in rats with chronic intestinal inflammation. Methods: Rats selected at either active or reactive phases and from 2 to 60 days after indomethacin treatment were used. mRNA expression of both constitutive and inducible NOS and COX isoforms in each phase was evaluated by RT-PCR and cellular enzyme localization by immunohistochemistry. The effects of different COX and NOS inhibitors on the intestinal motor activity were tested. Results: mRNA expression of COX-1 was not modified by inflammation whereas mRNA expression of nNOS was reduced in all indomethacin treated rats. In contrast, NOS and COX inducible forms showed a cyclical oscillation. mRNA expression and protein of both iNOS and COX-2 increased only during active phases. The intestinal hypomotility associated with active phases was turned into hypermotility after the administration of selective iNOS inhibitors. Conclusions: Sustained down-regulation of constitutive NOS caused hypermotility, possibly as a defense mechanism. However, this reaction was masked during the active phases due to the inhibitory effects of nitric oxide resulting from the increased levels of inducible NOS isoform.
This article has been cited by other articles:
![]() |
M. Porras, M. T. Martin, E. Teran, M. Mourelle, and P. Vergara The Nitric Oxide Donor LA-419 [S-(6-Nitro-oxi-hexahydro-furo[3,2-b]furan-3-1-il)thioacetate] Prevents Intestinal Dysmotility, Bacterial Translocation, and Inflammation in a Rat Model of Enteritis J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sitmo, M. Rehn, and M. Diener Stimulation of voltage-dependent Ca2+ channels by NO at rat myenteric neurons Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G886 - G893. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |